Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Asset Utilization Ratio (2016 - 2025)

China Pharma Holdings' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.18 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 44.57% year-over-year to 0.18; the TTM value through Dec 2025 reached 0.18, down 44.57%, while the annual FY2025 figure was 0.18, 37.47% down from the prior year.
  • Asset Utilization Ratio reached 0.18 in Q4 2025 per CPHI's latest filing, down from 0.27 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.56 in Q1 2021 to a low of 0.18 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.42, with a median of 0.43 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: rose 28.07% in 2021, then tumbled 44.57% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.47 in 2021, then grew by 0.98% to 0.48 in 2022, then decreased by 7.6% to 0.44 in 2023, then dropped by 27.5% to 0.32 in 2024, then plummeted by 44.57% to 0.18 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Asset Utilization Ratio are 0.18 (Q4 2025), 0.27 (Q3 2025), and 0.31 (Q2 2025).